PncA gene mutations associated with pyrazinamide resistance in drug-resistant Tuberculosis, South Africa and Georgia

Salim Allana, Elena Shashkina, Barun Mathema, Nino Bablishvili, Nestani Tukvadze, N. Sarita Shah, Russell R. Kempker, Henry M. Blumberg, Pravi Moodley, Koleka Mlisana, James C.M. Brust, Neel R. Gandhi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is not routinely available. We found polymorphisms in the pncA gene for 70% of multidrug-resistant and 96% of extensively drugresistant Mycobacterium tuberculosis isolates from South Africa and Georgia. Assessment of pyrazinamide susceptibility may be prudent before using it in regimens for drugresistant tuberculosis.

Original languageEnglish (US)
Pages (from-to)491-495
Number of pages5
JournalEmerging Infectious Diseases
Volume23
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Pyrazinamide
Multidrug-Resistant Tuberculosis
South Africa
Tuberculosis
Mutation
Mycobacterium tuberculosis
Genes
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Allana, S., Shashkina, E., Mathema, B., Bablishvili, N., Tukvadze, N., Shah, N. S., ... Gandhi, N. R. (2017). PncA gene mutations associated with pyrazinamide resistance in drug-resistant Tuberculosis, South Africa and Georgia. Emerging Infectious Diseases, 23(3), 491-495. https://doi.org/10.3201/eid2303.161034

PncA gene mutations associated with pyrazinamide resistance in drug-resistant Tuberculosis, South Africa and Georgia. / Allana, Salim; Shashkina, Elena; Mathema, Barun; Bablishvili, Nino; Tukvadze, Nestani; Shah, N. Sarita; Kempker, Russell R.; Blumberg, Henry M.; Moodley, Pravi; Mlisana, Koleka; Brust, James C.M.; Gandhi, Neel R.

In: Emerging Infectious Diseases, Vol. 23, No. 3, 01.03.2017, p. 491-495.

Research output: Contribution to journalArticle

Allana, S, Shashkina, E, Mathema, B, Bablishvili, N, Tukvadze, N, Shah, NS, Kempker, RR, Blumberg, HM, Moodley, P, Mlisana, K, Brust, JCM & Gandhi, NR 2017, 'PncA gene mutations associated with pyrazinamide resistance in drug-resistant Tuberculosis, South Africa and Georgia', Emerging Infectious Diseases, vol. 23, no. 3, pp. 491-495. https://doi.org/10.3201/eid2303.161034
Allana, Salim ; Shashkina, Elena ; Mathema, Barun ; Bablishvili, Nino ; Tukvadze, Nestani ; Shah, N. Sarita ; Kempker, Russell R. ; Blumberg, Henry M. ; Moodley, Pravi ; Mlisana, Koleka ; Brust, James C.M. ; Gandhi, Neel R. / PncA gene mutations associated with pyrazinamide resistance in drug-resistant Tuberculosis, South Africa and Georgia. In: Emerging Infectious Diseases. 2017 ; Vol. 23, No. 3. pp. 491-495.
@article{ea421ecc4ed4464d885a5f419df7ec56,
title = "PncA gene mutations associated with pyrazinamide resistance in drug-resistant Tuberculosis, South Africa and Georgia",
abstract = "Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is not routinely available. We found polymorphisms in the pncA gene for 70{\%} of multidrug-resistant and 96{\%} of extensively drugresistant Mycobacterium tuberculosis isolates from South Africa and Georgia. Assessment of pyrazinamide susceptibility may be prudent before using it in regimens for drugresistant tuberculosis.",
author = "Salim Allana and Elena Shashkina and Barun Mathema and Nino Bablishvili and Nestani Tukvadze and Shah, {N. Sarita} and Kempker, {Russell R.} and Blumberg, {Henry M.} and Pravi Moodley and Koleka Mlisana and Brust, {James C.M.} and Gandhi, {Neel R.}",
year = "2017",
month = "3",
day = "1",
doi = "10.3201/eid2303.161034",
language = "English (US)",
volume = "23",
pages = "491--495",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "3",

}

TY - JOUR

T1 - PncA gene mutations associated with pyrazinamide resistance in drug-resistant Tuberculosis, South Africa and Georgia

AU - Allana, Salim

AU - Shashkina, Elena

AU - Mathema, Barun

AU - Bablishvili, Nino

AU - Tukvadze, Nestani

AU - Shah, N. Sarita

AU - Kempker, Russell R.

AU - Blumberg, Henry M.

AU - Moodley, Pravi

AU - Mlisana, Koleka

AU - Brust, James C.M.

AU - Gandhi, Neel R.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is not routinely available. We found polymorphisms in the pncA gene for 70% of multidrug-resistant and 96% of extensively drugresistant Mycobacterium tuberculosis isolates from South Africa and Georgia. Assessment of pyrazinamide susceptibility may be prudent before using it in regimens for drugresistant tuberculosis.

AB - Although pyrazinamide is commonly used for tuberculosis treatment, drug-susceptibility testing is not routinely available. We found polymorphisms in the pncA gene for 70% of multidrug-resistant and 96% of extensively drugresistant Mycobacterium tuberculosis isolates from South Africa and Georgia. Assessment of pyrazinamide susceptibility may be prudent before using it in regimens for drugresistant tuberculosis.

UR - http://www.scopus.com/inward/record.url?scp=85013271771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013271771&partnerID=8YFLogxK

U2 - 10.3201/eid2303.161034

DO - 10.3201/eid2303.161034

M3 - Article

VL - 23

SP - 491

EP - 495

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 3

ER -